EquityZen Growth Technology Fund LLC - Series 1116
Raised
$6M
Investors
87
Min Invest
$2,292
AltStreet Analysis
·Generated from EDGAR primary sources
EquityZen Growth Technology Fund LLC - Series 1116 is a Delaware-registered pooled investment fund filed by EquityZen Advisors LLC that raised $5.9M from 87 investors under Rule 506(b) and 3(c)(1) exemptions. The fund features a $2K minimum investment and is part of the EquityZen platform, which operates nearly 1,900 pre-IPO investment vehicles. Filing date was December 2, 2021.
This pre-IPO fund employs the standard 506(b)/3(c)(1) exemption structure typical of accredited investor platforms, with a $2K minimum that positions it in the low-barrier retail-alternative tier. The 87-investor count and $5.9M raise indicate an average investment of approximately $68K, consistent with pooled secondary-market access vehicles targeting individual accredited investors rather than institutional allocators.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govRelated Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
EquityZen Advisors LLC
Executive Officer, Director · New York, NY
Richard Thoms
Executive Officer · Salt Lake City, UT
Assure Fund Management II LLC
Director · Salt Lake City, UT
Philip Haslett
Executive Officer, Director · New York, NY
Is this your offering?
Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.
